In The News

PD-CoRE improves memory, problem-solving, and depression in small study Written by Marisa Horak, MS | Sept. 29, 2026 Parkinson's disease often causes nonmotor symptoms such as cognitive decline, memory loss, impaired problem-solving, and depression. The PD-CoRE...

Neurosurgery team performs first dual-target approach in the Rocky Mountain region 5 minute read by Chris Casey | September 15, 2026 The takeaway: Researchers and physicians at CU Anschutz performed the Rocky Mountain region’s first dual-target high-intensity focused...

ACI-7104 was generally safe, triggered an immune response against its target Written by Andrea Lobo | Sept. 28, 2026 The experimental vaccine ACI-7104 targets early Parkinson’s disease by aiming to reduce toxic alpha-synuclein clumps in the brain. Initial Phase 2...

By Isabella Backman September 10, 2026 A new clinical trial led by Yale School of Medicine's Jesse Cedarbaum, MD, professor of neurology, and David Hafler, MD, William S. and Lois Stiles Edgerly Professor of Neurology, is the first such study to test whether a drug...

Study highlights need for holistic assessment and care plans Written by Marisa Horak, MS | Sept. 22, 2026 Parkinson's disease significantly affects a patient's health-related quality of life, beyond traditional motor symptoms. Quality-of-life determinants include age,...

— FDA gives go-ahead to D1/D5 dopamine agonist tavapadon by Judy George, Deputy Managing Editor, MedPage Today September 28, 2026  The FDA approved the dopamine agonist tavapadon (Juvmo) to treat adults with Parkinson's disease, drugmaker AbbVie announced Monday....

By Simon Spichak, MSc Published On: September 14, 2026 Scientists are studying whether changes in gut bacteria and nerves might be the earliest signs of Parkinson’s. Since constipation and other gastrointestinal symptoms may precede Parkinson’s by decades, researchers...

2 Sep 2026  - American Medical Journal - Author: Rana Zarour Key Summary: Molecular net charge governs single-chain variable fragment solubility and stability in human cells. Deep learning redesign enables functional intrabody creation for sixty intracellular disease...

But some benefits were seen in analyses after end of brief, small program Written by Michela Luciano, PhD | Sept. 23, 2026 Anxiety is known to trigger or significantly worsen freezing of gait, or FOG, a symptom common in people with Parkinson’s. However, an...

It led to greater improvements than Tai Chi in balance, walking speed, and more Written by Patricia Inácio, PhD | Sept. 25, 2026 Parkinson's disease patients experience mobility limitations and gait difficulties that contribute to falls and a reduced quality of life....